$SEM

TAVENNER MARILYN B sold (to issuer) $595K of SEM

TAVENNER MARILYN B sold (to issuer) 36,035 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($0.59M total) on 2026-06-30.

Original reporting
SEC EDGAR · TAVENNER MARILYN B
Published Jul 1, 2026, 6:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
medium confidence
Mentioned
$SEM
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The newest concrete fact is the director’s sale to the issuer of 36,035 shares at $16.50 on 2026-06-30, leaving 0 shares after the transaction.

02

Market read

Traders may monitor for follow-on insider activity, but this single Form 4 sale is unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

No 10b5-1 plan is stated, but the filing still lacks context on why the director sold (taxes, diversification, scheduled program, or corporate action mechanics).

Relevance 5/10Novelty 3/10Timing: after-hours/filing timestamp (2026-07-01) for the 2026-06-30 insider sale

Background

The filing is an SEC Form 4 insider transaction for Select Medical Holdings Corp (SEM).

Company-level read

Ticker impact

$SEMNeutralMedium confidence
Context

Select Medical Holdings director Marilyn B Tavenner sold 36,035 shares to the issuer for about $594.6K on 2026-06-30 (Form 4).

Expected impact

Low near-term impact; any reaction is likely noise unless paired with other disclosures.

Evidence & confidence

Form 4 insider transactions are typically informational but not usually directional without context (e.g., large size vs float, repeated selling, or concurrent operational news). Here the article provides only the sale details and indicates holdings drop to 0 shares.

Market effects

Minimal; insider sale in a single healthcare services name does not materially change sector expectations.

None indicated.

None indicated.

Counterpoint

The sale is explicitly “to issuer” (often buyback participation), which can be mechanical rather than a bearish signal.

Key entities

  • SELECT MEDICAL HOLDINGS CORP

    Subject of the Form 4 insider transaction; director sold shares to the issuer.

  • TAVENNER MARILYN B

    Director who sold 36,035 shares to the issuer for $594,577.50.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.